Blogs Inicio » General » Bosentas 62.5
Bosentas 62.5
  • Etiquetas - #Bosentas 62.5
    • Última actualización 2 de noviembre de 2022
    • 0 comentarios, 142 vistas, 0 likes

More from AllGenericcure Pharmacy

  • Aziderm Cream
    0 comentarios, 0 likes
  • Premarin Tablets
    0 comentarios, 0 likes
  • Anti Addiction
    0 comentarios, 0 likes

Related Blogs

  • Comment une entreprise de nettoyage de toiture peut-elle revitaliser votre maison ?
    0 comentarios, 0 likes
  • Discover the Ultimate Comfort: Unveiling the Secrets of Swivel Armchairs You Never Knew!
    0 comentarios, 0 likes
  • The Ultimate Guide to Finding the Perfect Hobo HatThe classic hobo hat captures carefree wanderlust and adventurous living. Its wide brims and loose style nod to vagrant ramblers riding the rails ages ago. Though originally utilitarian headgear for labore
    0 comentarios, 0 likes

Archivo

compartir social

Bosentas 62.5

Publicado por AllGenericcure Pharmacy     2 de noviembre de 2022    

Cuerpo



What is Bosentas 62.5?
Bosentas 62.5 is medicine to treat pulmonary arterial hypertension. Pulmonary arterial hypertension causes high pressure in the blood vessels carrying blood to the lungs from the heart. The active ingredient is Bosentas and sold under the brand name Tracleer.


Check out right here :- Xtane



Manufacturer?
It is manufactured in India by Cipla.

Uses?
Treat increased high pressure and blood pressure
Ulcers on fingertips and knuckles
Pneumonia
Who cannot take Bosentas 62.5?
Women who are pregnant or planning pregnancy. Being belong to category x you should not consume it in pregnancy.

Patients who are having any type of liver disease should not consume. It can cause significant damage to the liver.

Click here for more information :-Asthalin Rotacaps


Side effects?
It can cause great damage to the liver.
Edema (more absorption of water)
Headache
Anemia
Swelling in Ankles
Infection in the respiratory tract
Where to buy Bosentas 62.5?
Buy bosentas 62.5 online at Allgenericcure.



Read more

Comentarios

0 comentarios